Literature DB >> 17822746

Physiological modulation of voltage-dependent inactivation in the cardiac muscle L-type calcium channel: a modelling study.

Ian Findlay1, Shingo Suzuki, Shingo Murakami, Yoshihisa Kurachi.   

Abstract

The inactivation of the L-type Ca2+ current is composed of voltage-dependent and calcium-dependent mechanisms. The relative contribution of these processes is still under dispute and the idea that the voltage-dependent inactivation could be subject to further modulation by other physiological processes had been ignored. This study sought to model physiological modulation of inactivation of the current in cardiac ventricular myocytes, based upon the recent detailed experimental data that separated total and voltage-dependent inactivation (VDI) by replacing extracellular Ca2+ with Mg2+ and monitoring L-type Ca2+ channel behaviour by outward K+ current flowing through the channel in the absence of inward current flow. Calcium-dependent inactivation (CDI) was based upon Ca2+ influx and formulated from data that was recorded during beta-adrenergic stimulation of the myocytes. Ca2+ influx and its competition with non-selective monovalent cation permeation were also incorporated into channel permeation in the model. The constructed model could closely reproduce the experimental Ba2+ and Ca2+ current results under basal condition where no beta-stimulation was added after a slight reduction of the development of fast voltage-dependent inactivation with depolarization. The model also predicted that under beta-adrenergic stimulation voltage-dependent inactivation is lost and calcium-dependent inactivation largely compensates it. The developed model thus will be useful to estimate the respective roles of VDI and CDI of L-type Ca2+ channels in various physiological and pathological conditions of the heart which would otherwise be difficult to show experimentally.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17822746     DOI: 10.1016/j.pbiomolbio.2007.07.002

Source DB:  PubMed          Journal:  Prog Biophys Mol Biol        ISSN: 0079-6107            Impact factor:   3.667


  8 in total

1.  Roles of subcellular Na+ channel distributions in the mechanism of cardiac conduction.

Authors:  Kunichika Tsumoto; Takashi Ashihara; Ryo Haraguchi; Kazuo Nakazawa; Yoshihisa Kurachi
Journal:  Biophys J       Date:  2011-02-02       Impact factor: 4.033

2.  The mechanisms underlying ICa heterogeneity across murine left ventricle.

Authors:  Lin Xu; Xu-Yong Li; Yu Liu; Hai-Tao Li; Jing Chen; Xiao-Yan Li; Xue-Jun Jiang; Gang Wu; Yan-Hong Tang; Xi Wang; Cong-Xin Huang
Journal:  Mol Cell Biochem       Date:  2011-03-04       Impact factor: 3.396

Review 3.  Puerarin injection for treatment of unstable angina pectoris: a meta-analysis and systematic review.

Authors:  Zhisheng Gao; Baozhu Wei; Cheng Qian
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 4.  Interplay of voltage and Ca-dependent inactivation of L-type Ca current.

Authors:  Eleonora Grandi; Stefano Morotti; Kenneth S Ginsburg; Stefano Severi; Donald M Bers
Journal:  Prog Biophys Mol Biol       Date:  2010-02-23       Impact factor: 3.667

5.  Pharmacological preconditioning by diazoxide downregulates cardiac L-type Ca(2+) channels.

Authors:  G González; D Zaldívar; Ed Carrillo; A Hernández; Mc García; Ja Sánchez
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

6.  Ischemia-related subcellular redistribution of sodium channels enhances the proarrhythmic effect of class I antiarrhythmic drugs: a simulation study.

Authors:  Kunichika Tsumoto; Takashi Ashihara; Ryo Haraguchi; Kazuo Nakazawa; Yoshihisa Kurachi
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

7.  A bilobal model of Ca2+-dependent inactivation to probe the physiology of L-type Ca2+ channels.

Authors:  Worawan B Limpitikul; Joseph L Greenstein; David T Yue; Ivy E Dick; Raimond L Winslow
Journal:  J Gen Physiol       Date:  2018-11-23       Impact factor: 4.086

Review 8.  Effects of Puerarin on the Prevention and Treatment of Cardiovascular Diseases.

Authors:  Yan-Xi Zhou; Hong Zhang; Cheng Peng
Journal:  Front Pharmacol       Date:  2021-12-07       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.